Article · 13 Feb 2026
Conference abstractPublished 8 Sep 2014
Pharmaceutics and novel drug delivery systems
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Novel Drug delivery System (NDDS) refers to the approaches, formulations, technologies, and systems for transporting a pharmaceutical compound in the body as needed to safely achieve its desired therapeutic effects. It may involve scientific site-targeting within the body, or it might involve facilitating systemic pharmacokinetics; in any case, it is typically concerned with both quantity and duration of drug presence. Novel drug delivery is often approached via a drug?s chemical formulation, but it may also involve medical devices or drug-device combination products. Drug delivery is a concept heavily integrated with dosage form and route of administration. NDDS is advanced drug delivery system which improves drug potency, control drug release to give a sustained therapeutic effect, provide greater safety; finally it is to target a drug specifically to a desired tissue. NDDS is a system for delivery of drug other than conventional drug delivery system. NDDS is a combination of advance technique and new dosage forms which are far better than conventional dosage forms. Advantages of novel drug delivery system are: ? Optimum dose at the right time and right location ? Efficient use of expensive drugs, excipients and reduction in production cost ? Beneficial to patients, better therapy, improved comfort and standard of living Basic modes of novel drug delivery systems are: ? Targeted Drug Delivery System ? Controlled Drug Delivery System ? Modulated Drug Delivery System Factors affecting the design of controlled release products are: ? Physicochemical properties of a drug ? Route of administration ? Acute/Chronic therapy ? Target sites ? The Patient ? The disease state/level
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Pharmaceutical Regulatory Affairs: Open Access.
Article · 11 Feb 2026
EU GMP Annex 1 of 2022: A View in Depth
Article · 11 Feb 2026
Standard Formats Used in Drug Regulatory Submissions and Software Used
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutical Regulatory Affairs: Open Access
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Tariq Jamshaid”

